TickerFacts.

Endonovo Therapeutics, Inc. (ENDV): EPS (Basic)

Annual figures by period end, from SEC filings.

Not updated since 2022-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$0.13
Year ended 2022-12-31
2021-12-31: -$0.052022-12-31: -$0.13-$0.13
2021-12-31 EPS (Basic) (USD per share) 2022-12-31
Period endedEPS (Basic)Change YoYSource filing
2022-12-31-$0.13n/m2023-04-17, From 2022-01-01
2021-12-31-$0.05n/a2023-04-17, From 2021-01-01